Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Unifying link between Noonan's and Leopard syndromes?

L C Blieden, A Schneeweiss, A Shem-Tov

    Pediatric Cardiology
    |April 1, 1983
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Final results of the INFINITY precision oncology registry: non-standard targeted treatments in patients with advanced cancers in routine care.

    ESMO real world data and digital oncology·2026
    Same author

    Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC.

    Nature·2026
    Same author

    Long-term effect of neoadjuvant denosumab treatment in high-risk early breast cancer (GeparX).

    ESMO open·2025
    Same author

    Safety and efficacy of tiragolumab, atezolizumab and chemotherapy for early-stage or PD-L1-positive advanced triple-negative breast cancer: a phase Ib study.

    ESMO open·2025
    Same author

    Long-term outcomes of a randomized, open-label, phase II study comparing cabazitaxel versus paclitaxel as neoadjuvant treatment in patients with triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE).

    ESMO open·2024
    Same author

    Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST).

    Annals of oncology : official journal of the European Society for Medical Oncology·2023